Fluid status monitoring with a wireless network to reduce cardiovascular-related hospitalizations and mortality in heart failure: Rationale and design of the OptiLink HF Study (Optimization of Heart Failure Management using OptiVol Fluid Status Monitoring and Care)

European Journal of Heart Failure

Volumn 13, Issue 7, 2011, Pages 796-804

  Brachmann, Johannes ^a   Böhm, Michael ^b   Rybak, Karin ^c   Klein, Gunnar ^d   Butter, Christian ^e   Klemm, Hanno ^f   Schomburg, Rolf ^g   Siebermair, Johannes ^h   Israel, Carsten ⁱ   Sinha, Anil Martin ^a   Drexler, Helmut ^d  

^a KLINIKUM COBURG   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c Kardiologische Praxis   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e Herzzentrum Brandenburg   (Germany)

^f KLINIKUM DORTMUND   (Germany)

^g Segeberger Kliniken GmbH   (Germany)

^h LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

ⁱ EVANGELISCHES KRANKENHAUS   (Germany)

Author keywords

Bioimpedance; Cardiac resynchronization therapy; Chronic heart failure; Disease management; Implantable defibrillator; Telemedicine

Indexed keywords

ALGORITHM; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CONGESTIVE HEART FAILURE; DEFIBRILLATOR; DEVICE; EARLY DIAGNOSIS; FLUID BALANCE; HEART FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; TELEMEDICINE;

ALGORITHMS; CARDIOGRAPHY, IMPEDANCE; DISEASE MANAGEMENT; HEALTH STATUS; HEART FAILURE; HUMANS; MULTICENTER STUDIES AS TOPIC; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RESEARCH DESIGN; WATER-ELECTROLYTE BALANCE; WIRELESS TECHNOLOGY;

EID: 79959962424     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfr045     Document Type: Article

References (30)

1. Stewart S, MacIntyre K, MacLeod MM, Bailey AE, Capewell S, McMurray JJ. Trends in hospitalization for heart failure in Scotland, 1990-1996. An epidemic that has reached its peak? Eur Heart J 2001;22:209-217. (Pubitemid 32622471)
2. Cleland JG, Gemmell I, Khand A, Boddy A. Is the prognosis of heart failure improving? Eur J Heart Fail 1999;1:229-241. (Pubitemid 30129391)
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883. (Pubitemid 34984635)
4. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352:225-237. (Pubitemid 40110811)
5. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM, Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150.
6. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NAM III, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W, MADIT-CRT Trial Investigators. Cardiac resynchronization therapy for the prevention of heart failure events. N Engl J Med 2009;361: 1329-1338.
7. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJV, Ponikowski P, Poole-Wilson PA, Strömberg A, Van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebezaa A, Nieminen M, Priori S, Swedberg K, on behalf of the Task Force for the Diagnosis Treatment of Acute, Chronic Heart Failure 2008 of the European Society of Cardiology. Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur J Heart Fail 2008;10:933-989.
8. Jaarsma T, Van der Wal MHL, Lesman-Leegte I, Luttik ML, Hogenhuis J, Veeger NJ, Sanderman R, Hoes AW, Van Gilst WH, Lok DJA, Dunselman PHJM, Tijsen JGP, Hillege HL, Van Veldhuisen DJ, for the COACH Study Group. Effect of moderate or intensive disease management program on outcome in patients with heart failure. The Coordinating study evaluating Outcomes of Advising and Counseling in Heart failure (COACH). Arch Intern Med 2008;168:316-324.
9. Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J, Ponikowski P, Priori SG, Sutton R, van Veldhuisen DJ. 2010 focused update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur J Heart Fail 2010;12:1143-1153.
10. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549. (Pubitemid 40517094)
11. Van Veldhuisen DJ, Maass AH, Priori SG, Stolt P, van Gelder IC, Dickstein K, Swedberg K. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. Eur J Heart Fail 2009;11: 1143-1151.
12. Yu CM, Wang L, Chau E, Chan RH, Kong SL, Tang MO, Christensen J, Stadler RW, Lau CP. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 2005;112:841-848. (Pubitemid 41170070)
13. Luthje L, Drescher T, Zenker D, Vollmann D. Detection of heart failure decompensation using intrathoracic impedance monitoring by a triple-chamber implantable defibrillator. Heart Rhythm 2005;2:997-999. (Pubitemid 41372291)
14. Ypenburg C, Bax JJ, van der Wall EE, Schalij MJ, van Erven L. Intrathoracic impedance monitoring to predict decompensated heart failure. Am J Cardiol 2007;99: 554-557. (Pubitemid 46215562)
15. Vollmann D, Nägele H, Schauerte P, Wiegand U, Butter C, Zanotto G, Quesada A, Guthmann A, Hill MR, Lamp B, European InSync Sentry Observational Study Investigators. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. Eur Heart J 2007;28:1835-1840. (Pubitemid 47236638)
16. Tang WHW, Tong W. Measuring impedance in congestive heart failure: current options and clinical applications. Am Heart J 2009;157:402-411.
17. Marzegalli M, Lunati M, Landolina M, Perego GB, Ricci RP, Guenzati G, Schirru M, Belvito C, Brambilla R, Masella C, Di Stasi F, Valsecchi S, Santini M. Remote monitoring of CRT-ICD: the multicenter Italian CareLink evaluation-ease of use, acceptance, and organizational implications. Pacing Clin Electrophysiol 2008;31: 1259-1264.
18. Santini M, Ricci RP, Lunati M, Landolina M, Perego GB, Marzegalli M, Schirru M, Belvito C, Brambilla R, Guenzati G, Gilardi S, Valsecchi S. Remote monitoring of patients with biventricular defibrillators through the CareLink system improves clinical management of arrhythmias and heart failure episodes. J Interv Card Electrophysiol 2009;24:53-61.
19. Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, Gasparini M, Linde C, Morgado FB, Oto A, Sutton R, Trusz-Gluza M. Guidelines for cardiac pacing and cardiac resynchronization therapy. Eur Heart J 2007;28: 2256-2295.
20. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol 2000;35:1245-1255. (Pubitemid 30206900)
21. EuroQol Group. EuroQol-a new facility for the measurement of health related quality of life. Health Policy 1990;16:199-208.
22. Lakatos E. Sample sizes based on the log-rank statistic in complex clinical trials. Biometrics 1988;44:229-241. (Pubitemid 18098824)
23. Cantor AB. Extending the SAS Survival Analysis Techniques for Medical Research. Cary, NC, USA: SAS Institute; 1997.
24. Cowie MR, Conraads V, Tavazzi L, Yu CM, SENSE-HF Investigators. Rationale and design of a prospective trial to assess the sensitivity and positive predictive value of implantable intrathoracic impedance monitoring in the prediction of heart failure hospitalizations: the SENSE-HF study. J Card Fail 2009;15:394-400.
25. Braunschweig F, Ford I, Conraads V, Cowie MR, Jondeau G, Kautzner J, Lunati M, Munoz Aguilera R, Man Yu C, Marijianowski M, Borggrefe M, van Veldhuisen DJ, DOT-HF steering committee and investigators. Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure?. Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF). Eur J Heart Fail 2008;10:907-916.
26. Cleland JG, Louis AA, Rigby AS, Janssens U, Balk AH, TEN-HMS Investigators. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home- Care Management System (TEN-HMS) study. J Am Coll Cardiol 2005;45: 1654-1664. (Pubitemid 40704502)
27. Chaudhry SI, Mattera JA, Curtis JP, Spertus JA, Herrin J, Lin Z, Phillips CO, Hodshon BV, Cooper LS, Krumholz HM. Telemonitoring in patients with heart failure. N Engl J Med 2010;363:2301-2309.
28. Koehler F, Winkler S, Schieber M, Sechtem U, Stangl K, Böhm M, Boll H, Kim SS, Koehler K, Lücke S, Honold M, Heinze P, Schweizer T, Braecklein M, Kirwan BA, Gelbrich G, Anker SD, TIM-HF Investigators. Telemedical Interventional Monitoring in Heart Failure (TIM-HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design. Eur J Heart Fail 2010;12:1354-1362.
29. Buck S, Rienstra M, Maass AH, Nieuwland W, Van Veldhuisen DJ, Van Gelder IC. Cardiac resynchronization therapy in patients with heart failure and atrial fibrillation: importance of new-onset atrial fibrillation and total atrial conduction time. Europace 2008;10:558-565. (Pubitemid 351775289)
30. Neuberger HR, Mewis C, van Veldhuisen DJ, Schotten U, van Gelder IC, Allessie MA, Böhm M. Management of atrial fibrillation in patients with heart failure. Eur Heart J 2007;28:2568-2577. (Pubitemid 350071511)